glp 1 vs ddp4 The Role of DPP-4 Inhibitors in the Treatment Algorithm of Type 2 Diabetes Mellitus: When to Select, What to Expect GLP-1-based therapies: current knowledge of

A cutoff value of 20 s was used to prevent tissue damage

Endocrine 74(3):508517

Antismoking agents do not contribute synergistically to semaglutides ability to reduce alcohol intake in rats

The third mechanism whereby diabetes upregulates ANGII/AT1R is ACE2 downregulation, resulting in local ANG (1-7) reduction and, consequently, in an imbalance of the RAS

Additionally, the positive outcomes of ongoing trials SURPASS-CVOT and SURMOUNT-MMO will provide definitive evidence regarding the cardiovascular safety and efficacy of tirzepatide compared to dulaglutide and reduction in morbiditiy and mortality in adults with obesity respectively